Compare GDTC & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDTC | SINT |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5M | 14.6M |
| IPO Year | 2023 | 2014 |
| Metric | GDTC | SINT |
|---|---|---|
| Price | $0.94 | $3.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 38.4K | ★ 41.4K |
| Earning Date | 04-24-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $573,193.00 | ★ $1,270,000.00 |
| Revenue This Year | $5.37 | N/A |
| Revenue Next Year | N/A | $80.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 63.03 | N/A |
| 52 Week Low | $0.89 | $1.71 |
| 52 Week High | $3.68 | $7.36 |
| Indicator | GDTC | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 20.48 | 50.94 |
| Support Level | $0.89 | $3.65 |
| Resistance Level | $1.39 | $3.94 |
| Average True Range (ATR) | 0.13 | 0.23 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 7.13 | 35.00 |
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.